Skip to main content

Ryan Jones

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ryan Jones

Ryan Jones was last confirmed as CFO at Kyverna Therapeutics, Inc. (KYTX) in a filing dated April 14, 2025. Kyverna Therapeutics, Inc. reported in an 8-K filed June 30, 2025 that Ryan Jones resigned as officer, manager or director, effective June 30, 2025.

“You agree that, effective as of the Advisor Date, you have resigned from (a) all positions that you held with the Company or any of its subsidiaries and affiliates, including, without limitation, officer, manager or director, but excluding your continued services as an employee pursuant to the terms of this Agreement, and (b) all fiduciary positions (including as a trustee) you held with respect to any employee benefit plans or trusts established by the Company or any affiliate.”
Kyverna Therapeutics, Inc. Form 8-K, filed June 30, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.